Delivery Order SPE2DB20D2104-SPE2DB25FMVXG
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,787.82 firm fixed-price delivery order is for the supply of 4,566,960 units of Candesartan Cilexetil 16 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,338.11 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets, with a period of performance through July 3, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,765.44 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets with an ultimate completion date of April 29, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,826,834 units of the prescription drug Candesartan Cilexetil 16 mg tablets. The firm-fixed-price delivery order contract has a ceiling value of $15,702.81 and an ultimate completion date of September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which does not have a set-aside designation. This contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,227.13 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The contract is not set-aside and has an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,347.24 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,523.86 firm-fixed-price delivery order is for the supply of 4,567,922,340 units of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $11,854.68 for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of July 22, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $5,528.55 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 32 mg Candesartan Cilexetil tablets in 90-count bottles, with a completion date of September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, which provides a range of...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,854.92, is a delivery order for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...